Aspirin Dosing in Patients Over 75 Years
For patients over 75 years old requiring aspirin for cardiovascular protection, use 75 mg daily without a loading dose in most clinical scenarios, with the critical exception being acute coronary syndromes where standard loading doses apply regardless of age.
Acute Coronary Syndromes (STEMI/NSTEMI)
Loading Dose
- Administer 162-325 mg loading dose immediately upon presentation, regardless of age 1, 2
- This applies even to patients already on maintenance aspirin therapy 2
- Use non-enteric coated formulation and have patient chew the tablet for faster onset 2
Maintenance Dose After Acute Event
- For patients >75 years: 75-100 mg daily (81 mg is the standard U.S. formulation) 1, 2
- Continue indefinitely as secondary prevention 1
Dual Antiplatelet Therapy Considerations in Elderly
With Clopidogrel
- Critical age-specific modification: For patients >75 years receiving clopidogrel after STEMI, give NO loading dose of clopidogrel (skip the 300 mg load), start directly with 75 mg daily 1
- Combine with aspirin 75-100 mg daily 1
- This reduced clopidogrel approach in elderly patients >75 years reflects increased bleeding risk 1
With Prasugrel
- Prasugrel is generally NOT recommended in patients ≥75 years due to increased risk of fatal and intracranial bleeding 1
- May consider only in very high-risk situations (diabetes or prior MI) where benefit may outweigh risk 1
Secondary Prevention (Stable Coronary Disease)
- Use 75-100 mg daily (81 mg standard U.S. dose) for long-term maintenance 1, 2
- This lower dose range (75-81 mg) optimizes efficacy while minimizing bleeding risk, which is particularly important in elderly patients 1, 3
Primary Prevention in Patients >75 Years
Do not initiate aspirin for primary prevention in patients ≥75 years old 1, 4
Key Evidence
- The balance of benefits versus bleeding risks is unfavorable in this age group 1
- For patients over 70 years without established cardiovascular disease, aspirin carries greater risk than benefit 1
- The 2022 U.S. Preventive Services Task Force recommends against initiating aspirin in adults ≥60 years for primary prevention 4
Bleeding Risk Mitigation
Critical Considerations in Elderly
- Older age is an independent risk factor for bleeding complications 1
- Major gastrointestinal bleeding risk increases to 4-12 per 1,000 older persons over 5 years (compared to 2-4 per 1,000 in middle-aged adults) 2
- Always use the lowest effective dose (75-81 mg) in elderly patients to minimize bleeding while maintaining efficacy 1, 3
Contraindications
- Active bleeding or bleeding tendency 2
- Concurrent anticoagulation (requires careful risk-benefit assessment) 1, 2
- Recent gastrointestinal bleeding 2
- Uncontrolled hypertension 2
Common Pitfalls to Avoid
- Do not use higher maintenance doses (>100 mg) in elderly patients - doses above 100 mg show no additional efficacy benefit but may increase bleeding risk, especially when combined with clopidogrel 3
- Do not give clopidogrel loading dose (300 mg) to patients >75 years in acute settings - start directly with 75 mg maintenance dose 1
- Do not continue or initiate aspirin for primary prevention in patients >75 years - bleeding risks outweigh cardiovascular benefits in this population 1, 4
- Do not use prasugrel routinely in patients ≥75 years - associated with increased fatal bleeding 1
Dosing Algorithm Summary
For patients >75 years:
- Acute MI/ACS: 162-325 mg loading dose → 75-100 mg daily maintenance 1, 2
- Established CVD (secondary prevention): 75-100 mg daily 1, 2
- Primary prevention: Do not initiate 1, 4
- With clopidogrel: Aspirin 75-100 mg + clopidogrel 75 mg (no clopidogrel loading dose) 1
- Preferred maintenance dose: 75-81 mg daily to optimize safety profile 1, 3